for example, the intestinal microbiota composition changes in response to manipulation of estrogen receptor (ER-) [103], and in response to hormonal imbalance, such as in polycystic ovary syndrome (PCOS), or pregnancy [104, 105]
While much has been published on cellular expression of GPCRs, including the GLP-1R, when evaluating the validity of such data it is key to consider the methodologies applied [e.g., immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), in situ ligand binding (ISBL)]
FDA approval represented a big step forward for people seeking medical solutions to help them achieve their body weight loss goals particularly for those with obesity or weight-related conditions like hypertension or high cholesterol
This is especially advantageous for hydrophilic or high molecular weight pharmaceuticals contained in liposomes, which encounter considerable permeability obstacles